Viral Load and CD4
Tuberculosis (TB) infection causes mortality among People Living with HIV (PLHIV), so the treatment of TB-HIV coinfection is crucial. The study aimed to identify the determinants contributing to TB co...
Activité de type insulinique non suppressible : Questions médicales fréquentes
Questions fréquentes et termes MeSH associés
Diagnostic 5
#1
Comment diagnostiquer l'activité insulinique non suppressible ?
Des tests sanguins mesurant les niveaux d'insuline et de glucose sont effectués.
#2
Quels tests sont utilisés pour évaluer cette condition ?
Le test de tolérance au glucose et les dosages d'insuline sont courants.
#3
Quels signes cliniques indiquent cette activité ?
Des symptômes comme l'hyperglycémie persistante peuvent être observés.
#4
L'imagerie est-elle utile pour le diagnostic ?
L'imagerie n'est généralement pas utilisée pour cette condition spécifique.
#5
Peut-on utiliser des biomarqueurs pour le diagnostic ?
Oui, des biomarqueurs comme le peptide C peuvent aider à évaluer l'insulinémie.
Symptômes 5
#1
Quels sont les symptômes courants de cette condition ?
Les symptômes incluent fatigue, soif excessive et besoin fréquent d'uriner.
#2
L'hypoglycémie est-elle un symptôme possible ?
Oui, des épisodes d'hypoglycémie peuvent survenir malgré une insulinémie élevée.
#3
Y a-t-il des symptômes liés à la prise de poids ?
Oui, une prise de poids inexpliquée peut être un symptôme associé.
#4
Les troubles de la vision sont-ils possibles ?
Oui, des troubles visuels peuvent survenir en raison de l'hyperglycémie prolongée.
#5
Des symptômes cutanés peuvent-ils apparaître ?
Oui, des infections cutanées fréquentes peuvent être un signe d'insulinorésistance.
Prévention 5
#1
Comment prévenir l'activité insulinique non suppressible ?
Maintenir un poids santé et adopter un mode de vie actif sont essentiels.
#2
L'alimentation joue-t-elle un rôle préventif ?
Oui, une alimentation équilibrée peut réduire le risque de résistance à l'insuline.
#3
Le dépistage précoce est-il important ?
Oui, le dépistage régulier peut aider à identifier les problèmes tôt.
#4
Le stress influence-t-il cette condition ?
Oui, le stress peut aggraver la résistance à l'insuline et les symptômes.
#5
Les habitudes de sommeil affectent-elles la prévention ?
Oui, un sommeil de qualité est crucial pour la régulation de l'insuline.
Traitements 5
#1
Quels traitements sont disponibles pour cette condition ?
Les traitements incluent des médicaments antidiabétiques et des modifications du mode de vie.
#2
L'insuline est-elle utilisée dans le traitement ?
Oui, l'insuline peut être administrée pour contrôler les niveaux de glucose.
#3
Les changements alimentaires sont-ils recommandés ?
Oui, un régime équilibré et pauvre en glucides est souvent conseillé.
#4
La thérapie physique peut-elle aider ?
Oui, l'exercice régulier peut améliorer la sensibilité à l'insuline.
#5
Des traitements alternatifs existent-ils ?
Certaines approches comme la médecine complémentaire peuvent être explorées.
Complications 5
#1
Quelles complications peuvent survenir ?
Des complications comme le diabète de type 2 et des maladies cardiovasculaires peuvent se développer.
#2
L'insulinorésistance peut-elle entraîner des complications ?
Oui, l'insulinorésistance est liée à des complications métaboliques graves.
#3
Des problèmes rénaux peuvent-ils se développer ?
Oui, des maladies rénales chroniques peuvent être une complication de cette condition.
#4
Les troubles neurologiques sont-ils possibles ?
Oui, des neuropathies peuvent survenir en raison de l'hyperglycémie prolongée.
#5
Y a-t-il un risque accru de maladies cardiaques ?
Oui, le risque de maladies cardiaques est significativement augmenté.
Facteurs de risque 5
#1
Quels sont les principaux facteurs de risque ?
L'obésité, le manque d'exercice et des antécédents familiaux sont des facteurs clés.
#2
L'âge influence-t-il le risque ?
Oui, le risque augmente avec l'âge, surtout après 45 ans.
#3
Le tabagisme est-il un facteur de risque ?
Oui, le tabagisme est associé à une augmentation de la résistance à l'insuline.
#4
Les antécédents médicaux jouent-ils un rôle ?
Oui, des antécédents de diabète gestationnel augmentent le risque futur.
#5
Le stress chronique est-il un facteur de risque ?
Oui, le stress chronique peut contribuer à l'insulinorésistance.
Contenu validé par Dr Olivier Menir
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 31/03/2025
Contenu vérifié selon les dernières recommandations médicales
Auteurs principaux
Jie Li
4 publications dans cette catégorie
Affiliations :
- Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Publications dans "Activité de type insulinique non suppressible" :
-
Activation of the insulin receptor by insulin-like growth factor 2.
Nature communications 2024-03-23
-
Structural basis of the activation of type 1 insulin-like growth factor receptor.
Nature communications 2019-10-08
-
Molecular basis for the role of disulfide-linked αCTs in the activation of insulin-like growth factor 1 receptor and insulin receptor.
eLife 2022-11-22
-
Activation of the insulin receptor by an insulin mimetic peptide.
Nature communications 2022-09-23
Xiao-Chen Bai
4 publications dans cette catégorie
Affiliations :
- Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA. Xiaochen.Bai@UTSouthwestern.edu.
- Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA. Xiaochen.Bai@UTSouthwestern.edu.
Publications dans "Activité de type insulinique non suppressible" :
-
Activation of the insulin receptor by insulin-like growth factor 2.
Nature communications 2024-03-23
-
Structural basis of the activation of type 1 insulin-like growth factor receptor.
Nature communications 2019-10-08
-
Molecular basis for the role of disulfide-linked αCTs in the activation of insulin-like growth factor 1 receptor and insulin receptor.
eLife 2022-11-22
-
Activation of the insulin receptor by an insulin mimetic peptide.
Nature communications 2022-09-23
Eunhee Choi
4 publications dans cette catégorie
Affiliations :
- Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, 10032, USA. EC3477@cumc.columbia.edu.
Publications dans "Activité de type insulinique non suppressible" :
-
Activation of the insulin receptor by insulin-like growth factor 2.
Nature communications 2024-03-23
-
Structural basis of the activation of type 1 insulin-like growth factor receptor.
Nature communications 2019-10-08
-
Molecular basis for the role of disulfide-linked αCTs in the activation of insulin-like growth factor 1 receptor and insulin receptor.
eLife 2022-11-22
-
Activation of the insulin receptor by an insulin mimetic peptide.
Nature communications 2022-09-23
Catherine Hall
3 publications dans cette catégorie
Affiliations :
- Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, 10032, USA.
Publications dans "Activité de type insulinique non suppressible" :
-
Activation of the insulin receptor by insulin-like growth factor 2.
Nature communications 2024-03-23
-
Molecular basis for the role of disulfide-linked αCTs in the activation of insulin-like growth factor 1 receptor and insulin receptor.
eLife 2022-11-22
-
Activation of the insulin receptor by an insulin mimetic peptide.
Nature communications 2022-09-23
Jiayi Wu
3 publications dans cette catégorie
Affiliations :
- Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, 10032, USA.
Publications dans "Activité de type insulinique non suppressible" :
-
Activation of the insulin receptor by insulin-like growth factor 2.
Nature communications 2024-03-23
-
Molecular basis for the role of disulfide-linked αCTs in the activation of insulin-like growth factor 1 receptor and insulin receptor.
eLife 2022-11-22
-
Activation of the insulin receptor by an insulin mimetic peptide.
Nature communications 2022-09-23
Junhee Park
2 publications dans cette catégorie
Affiliations :
- Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, 10032, USA.
Publications dans "Activité de type insulinique non suppressible" :
-
Activation of the insulin receptor by insulin-like growth factor 2.
Nature communications 2024-03-23
-
Activation of the insulin receptor by an insulin mimetic peptide.
Nature communications 2022-09-23
Christopher T V Swain
2 publications dans cette catégorie
Affiliations :
- Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
Publications dans "Activité de type insulinique non suppressible" :
-
Linking Physical Activity to Breast Cancer Risk via Insulin/Insulin-Like Growth Factor Signaling System, Part 1: The Effect of Physical Activity on the Insulin/Insulin-Like Growth Factor Signaling System.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
-
Linking Physical Activity to Breast Cancer Risk via the Insulin/Insulin-like Growth Factor Signaling System, Part 2: The Effect of Insulin/Insulin-like Growth Factor Signaling on Breast Cancer Risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Ann E Drummond
2 publications dans cette catégorie
Affiliations :
- Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
Publications dans "Activité de type insulinique non suppressible" :
-
Linking Physical Activity to Breast Cancer Risk via Insulin/Insulin-Like Growth Factor Signaling System, Part 1: The Effect of Physical Activity on the Insulin/Insulin-Like Growth Factor Signaling System.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
-
Linking Physical Activity to Breast Cancer Risk via the Insulin/Insulin-like Growth Factor Signaling System, Part 2: The Effect of Insulin/Insulin-like Growth Factor Signaling on Breast Cancer Risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Roger L Milne
2 publications dans cette catégorie
Affiliations :
- Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
- Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
- Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia.
Publications dans "Activité de type insulinique non suppressible" :
-
Linking Physical Activity to Breast Cancer Risk via Insulin/Insulin-Like Growth Factor Signaling System, Part 1: The Effect of Physical Activity on the Insulin/Insulin-Like Growth Factor Signaling System.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
-
Linking Physical Activity to Breast Cancer Risk via the Insulin/Insulin-like Growth Factor Signaling System, Part 2: The Effect of Insulin/Insulin-like Growth Factor Signaling on Breast Cancer Risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Dallas R English
2 publications dans cette catégorie
Affiliations :
- Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
- Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
Publications dans "Activité de type insulinique non suppressible" :
-
Linking Physical Activity to Breast Cancer Risk via Insulin/Insulin-Like Growth Factor Signaling System, Part 1: The Effect of Physical Activity on the Insulin/Insulin-Like Growth Factor Signaling System.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
-
Linking Physical Activity to Breast Cancer Risk via the Insulin/Insulin-like Growth Factor Signaling System, Part 2: The Effect of Insulin/Insulin-like Growth Factor Signaling on Breast Cancer Risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Kristy A Brown
2 publications dans cette catégorie
Affiliations :
- Department of Medicine, Weill Cornell Medicine, New York, New York.
Publications dans "Activité de type insulinique non suppressible" :
-
Linking Physical Activity to Breast Cancer Risk via Insulin/Insulin-Like Growth Factor Signaling System, Part 1: The Effect of Physical Activity on the Insulin/Insulin-Like Growth Factor Signaling System.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
-
Linking Physical Activity to Breast Cancer Risk via the Insulin/Insulin-like Growth Factor Signaling System, Part 2: The Effect of Insulin/Insulin-like Growth Factor Signaling on Breast Cancer Risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Tina L Skinner
2 publications dans cette catégorie
Affiliations :
- The University of Queensland, School of Human Movement and Nutrition Sciences, St. Lucia, Australia.
Publications dans "Activité de type insulinique non suppressible" :
-
Linking Physical Activity to Breast Cancer Risk via Insulin/Insulin-Like Growth Factor Signaling System, Part 1: The Effect of Physical Activity on the Insulin/Insulin-Like Growth Factor Signaling System.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
-
Linking Physical Activity to Breast Cancer Risk via the Insulin/Insulin-like Growth Factor Signaling System, Part 2: The Effect of Insulin/Insulin-like Growth Factor Signaling on Breast Cancer Risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Eline H van Roekel
2 publications dans cette catégorie
Affiliations :
- Department of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands.
Publications dans "Activité de type insulinique non suppressible" :
-
Linking Physical Activity to Breast Cancer Risk via Insulin/Insulin-Like Growth Factor Signaling System, Part 1: The Effect of Physical Activity on the Insulin/Insulin-Like Growth Factor Signaling System.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
-
Linking Physical Activity to Breast Cancer Risk via the Insulin/Insulin-like Growth Factor Signaling System, Part 2: The Effect of Insulin/Insulin-like Growth Factor Signaling on Breast Cancer Risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Melissa M Moore
2 publications dans cette catégorie
Affiliations :
- Medical Oncology, St. Vincent's Hospital, Melbourne, Australia.
- Department of Medicine, The University of Melbourne, Melbourne, Australia.
Publications dans "Activité de type insulinique non suppressible" :
-
Linking Physical Activity to Breast Cancer Risk via Insulin/Insulin-Like Growth Factor Signaling System, Part 1: The Effect of Physical Activity on the Insulin/Insulin-Like Growth Factor Signaling System.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
-
Linking Physical Activity to Breast Cancer Risk via the Insulin/Insulin-like Growth Factor Signaling System, Part 2: The Effect of Insulin/Insulin-like Growth Factor Signaling on Breast Cancer Risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Tom R Gaunt
2 publications dans cette catégorie
Affiliations :
- Bristol Medical School, University of Bristol, Bristol, United Kingdom.
Publications dans "Activité de type insulinique non suppressible" :
-
Linking Physical Activity to Breast Cancer Risk via Insulin/Insulin-Like Growth Factor Signaling System, Part 1: The Effect of Physical Activity on the Insulin/Insulin-Like Growth Factor Signaling System.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
-
Linking Physical Activity to Breast Cancer Risk via the Insulin/Insulin-like Growth Factor Signaling System, Part 2: The Effect of Insulin/Insulin-like Growth Factor Signaling on Breast Cancer Risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Richard M Martin
2 publications dans cette catégorie
Affiliations :
- Bristol Medical School, University of Bristol, Bristol, United Kingdom.
- IHR Biomedical Research Centre at University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, United Kingdom.
Publications dans "Activité de type insulinique non suppressible" :
-
Linking Physical Activity to Breast Cancer Risk via Insulin/Insulin-Like Growth Factor Signaling System, Part 1: The Effect of Physical Activity on the Insulin/Insulin-Like Growth Factor Signaling System.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
-
Linking Physical Activity to Breast Cancer Risk via the Insulin/Insulin-like Growth Factor Signaling System, Part 2: The Effect of Insulin/Insulin-like Growth Factor Signaling on Breast Cancer Risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Sarah J Lewis
2 publications dans cette catégorie
Affiliations :
- Bristol Medical School, University of Bristol, Bristol, United Kingdom.
Publications dans "Activité de type insulinique non suppressible" :
-
Linking Physical Activity to Breast Cancer Risk via Insulin/Insulin-Like Growth Factor Signaling System, Part 1: The Effect of Physical Activity on the Insulin/Insulin-Like Growth Factor Signaling System.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
-
Linking Physical Activity to Breast Cancer Risk via the Insulin/Insulin-like Growth Factor Signaling System, Part 2: The Effect of Insulin/Insulin-like Growth Factor Signaling on Breast Cancer Risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Brigid M Lynch
2 publications dans cette catégorie
Affiliations :
- Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
- Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
- Physical Activity Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.
Publications dans "Activité de type insulinique non suppressible" :
-
Linking Physical Activity to Breast Cancer Risk via Insulin/Insulin-Like Growth Factor Signaling System, Part 1: The Effect of Physical Activity on the Insulin/Insulin-Like Growth Factor Signaling System.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
-
Linking Physical Activity to Breast Cancer Risk via the Insulin/Insulin-like Growth Factor Signaling System, Part 2: The Effect of Insulin/Insulin-like Growth Factor Signaling on Breast Cancer Risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Carlie Delaine
2 publications dans cette catégorie
Affiliations :
- Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA 5042, Australia.
Publications dans "Activité de type insulinique non suppressible" :
-
Identification, Synthesis, Conformation and Activity of an Insulin-like Peptide from a Sea Anemone.
Biomolecules 2021-11-29
-
How insulin-like growth factor I binds to a hybrid insulin receptor type 1 insulin-like growth factor receptor.
Structure (London, England : 1993) 2022-06-03
Briony E Forbes
2 publications dans cette catégorie
Affiliations :
- Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA 5042, Australia.
Publications dans "Activité de type insulinique non suppressible" :
-
Identification, Synthesis, Conformation and Activity of an Insulin-like Peptide from a Sea Anemone.
Biomolecules 2021-11-29
-
How insulin-like growth factor I binds to a hybrid insulin receptor type 1 insulin-like growth factor receptor.
Structure (London, England : 1993) 2022-06-03
Sources (10000 au total)
Diagnostic Accuracy of the Rapid Xpert HIV-1 Viral Load XC, Xpert HIV-1 Viral Load, & m-PIMA HIV-1/2 Viral Load in South African Clinics.
We aimed to evaluate the analytic performance of 3 rapid HIV viral load assays: the novel Xpert HIV-1 VL XC (Xpert XC), Xpert HIV-1 VL (Xpert VL), and m-PIMA HIV-1/2 VL (m-PIMA).... Two South African clinics.... We conducted a prospective diagnostic accuracy study. Site-laboratory technicians and nurses used the Xpert XC, Xpert VL, and m-PIMA to test plasma samples from people with HIV receiving antiretrovira... We enrolled 140 participants (98 [70%] women, median age 37 years), who provided 189 paired samples at one or more timepoints. We tested 174 samples with the Xpert XC, 188 with the Xpert VL, and 128 w... In these South African clinics, the accuracy of all 3 assays was clinically acceptable to detect viraemia at the WHO failure threshold, whereas both Xpert assays were also accurate at detecting low-le...
Near point-of-care HIV viral load testing: Cascade after high viral load in suburban Yangon, Myanmar.
HIV viral load (VL) testing in resource-limited settings is often centralised, limiting access. In Myanmar, we assessed outcomes according to VL access and the VL cascade (case management after a firs... Routine programme data from people living with HIV (PLHIV) on antiretroviral therapy (ART) were used. We assessed the odds of getting a VL test done by year. Attrition and mortality two years after AR... Among 4291 PLHIV who started ART between July 2009 and June 2018, 794 (18.5%) became eligible for VL testing when it was not available, 2388 (55.7%) when centralised laboratory-based VL testing was av... Near POC VL testing enabled rapid increase of VL coverage and a well-managed VL cascade in Myanmar....
An SIR model with viral load-dependent transmission.
The viral load is known to be a chief predictor of the risk of transmission of infectious diseases. In this work, we investigate the role of the individuals' viral load in the disease transmission by ...
Qualitative plasma viral load determination as a tool for screening of viral reservoir size in PWH.
Suppression of viral replication in patients on antiretroviral therapy (ART) is determined by plasma viral load (pVL) measurement. Whenever pVL reaches values below the limit of quantification, the qu... The study recruited 114 people with HIV (PWH) who are stable on ART between 2016 and 2018. The percentage of pVL measurements qualitatively reported as 'target detected' (PTD) within a 2-year period w... t-DNA and US-RNA were used to estimate viral reservoir size and were quantified on peripheral blood mononuclear cells (PBMCs) using droplet digital PCR.... A median of 6.5 pVL measurements over a 2-year period was evaluated for each participant to calculate PTD. A positive correlation was found between t-DNA and PTD (r = 0.24; P = 0.011) but not between ... Our study shows that PTD provides an efficient parameter to preselect participants with a small viral reservoir based on already available pVL data for future HIV cure trials....
SARS-CoV-2 viral load and shedding kinetics.
SARS-CoV-2 viral load and detection of infectious virus in the respiratory tract are the two key parameters for estimating infectiousness. As shedding of infectious virus is required for onward transm...
SARS-CoV-2 Viral Load in the Pulmonary Compartment of Critically Ill COVID-19 Patients Correlates with Viral Serum Load and Fatal Outcomes.
While SARS-CoV-2 detection in sputum and swabs from the upper respiratory tract has been used as a diagnostic tool, virus quantification showed poor correlation to disease outcome and thus, poor progn...
The Relationship between Clinical Findings and Viral Load in Adenoviral Keratoconjunctivitis.
The aim of this study was to evaluate the relationship between clinical findings and viral load in adenoviral keratoconjunctivitis (Ad-Kc). In this cross-sectional study, 30 eyes of 30 patients with A...
Evaluation of HIV viral load turnaround time in Moshi, Tanzania.
Viral load measurement is an important gold standard for monitoring anti-retroviral treatment among people living with human immunodeficiency virus. The optimal use of the viral load results for guidi... This was a retrospective cohort study which involved patients receiving cART from 1 August 2018 to 31 January 2017 at three clinics in Tanzania. Data was extracted from patient files at the clinics an... 445 subjects had a viral load in test results and 88% had a viral load of > 1,000 copies/mL. The median duration on the current regimen was five years. Median time between the clinics receiving the re... The median viral load turnaround time was longer than stipulated by the national Tanzanian guidelines. Interventions that may reduce viral load turn-around-time, including point of care viral load tes...
HIV Viral Load Scale-up Among Children and Adolescents: Trends in Viral Load Suppression, Sample Type and Processing in 7 PEPFAR Countries, 2015-2018.
HIV-positive children and adolescents face gaps in viral load (VL) testing. To understand trends in pediatric/adolescent VL testing, 7 countries collected data from Laboratory Information Management S...